Jian-quan Luo

87 Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Host genetic variants in the lactose metabolism pathway associated with bifidobacterium abundance have prognostic value for immunotherapy efficacy.

Host genetic variants in the lactose metabolism pathway associated with bifidobacterium abundance have prognostic value for immunotherapy efficacy.

Journal: British journal of pharmacology

Published: October 14, 2025

Gut microbiome-targeted therapeutics for chronic kidney disease: comparative efficacy of probiotic and microbial preparations.

Gut microbiome-targeted therapeutics for chronic kidney disease: comparative efficacy of probiotic and microbial preparations.

Journal: Inflammopharmacology

Published: August 21, 2025

Lactobacillus reuteri attenuates methotrexate-induced liver injury via modulation of oxidative stress and inflammation through HO-1/GPX4 and NF-κB/NLRP3 pathways.

Lactobacillus reuteri attenuates methotrexate-induced liver injury via modulation of oxidative stress and inflammation through HO-1/GPX4 and NF-κB/NLRP3 pathways.

Journal: European journal of pharmacology

Published: May 23, 2025

Unraveling the effectiveness of new media teaching strategies in pharmacology education under different educational backgrounds: Insights from 6447 students.

Unraveling the effectiveness of new media teaching strategies in pharmacology education under different educational backgrounds: Insights from 6447 students.

Journal: European journal of pharmacology

Published: May 14, 2024

Comparison of the effectiveness of probiotic supplementation in glucose metabolism, lipid profile, inflammation and oxidative stress in pregnant women.

Comparison of the effectiveness of probiotic supplementation in glucose metabolism, lipid profile, inflammation and oxidative stress in pregnant women.

Journal: Food & function

Published: March 08, 2024

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM).

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM).

Journal: Frontiers in endocrinology

Published: September 02, 2023

Blood Group Antigen A Carriers Exhibit an Extended Progression-Free Survival with no more Immune-Related Adverse Events.

Blood Group Antigen A Carriers Exhibit an Extended Progression-Free Survival with no more Immune-Related Adverse Events.

Journal: Clinical pharmacology and therapeutics

Published: August 01, 2023

The human glucose and lipid homeostasis-associated genetic polymorphisms do not regulate SLC25A47 gene expression in the liver.

The human glucose and lipid homeostasis-associated genetic polymorphisms do not regulate SLC25A47 gene expression in the liver.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 31, 2023

Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19.

Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19.

Journal: Frontiers in immunology

Published: April 25, 2023

Hydrochlorothiazide-induced glucose metabolism disorder is mediated by the gut microbiota via LPS-TLR4-related macrophage polarization.

Hydrochlorothiazide-induced glucose metabolism disorder is mediated by the gut microbiota via LPS-TLR4-related macrophage polarization.

Journal: iScience

Published: January 20, 2023

Multidimensional evaluation of teaching strategies for pharmacology based on a comprehensive analysis involving 21,269 students.

Multidimensional evaluation of teaching strategies for pharmacology based on a comprehensive analysis involving 21,269 students.

Journal: Frontiers in pharmacology

Published: January 16, 2023

Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice.

Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 25, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026